Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: Proton pump inhibitors (PPIs) may interfere with calcium absorption through induction of hypochlorhydria but they also may reduce bone resorption through inhibition of osteoclastic vacuolar proton pumps. OBJECTIVE: To determine the association between PPI therapy and risk of hip fracture. DESIGN, SETTING, AND PATIENTS: A nested case-control study was conducted using the General Practice Research Database (1987-2003), which contains information on patients in the United Kingdom. The study cohort consisted of users of PPI therapy and nonusers of acid suppression drugs who were older than 50 years. Cases included all patients with an incident hip fracture. Controls were selected using incidence density sampling, matched for sex, index date, year of birth, and both calendar period and duration of up-to-standard follow-up before the index date. For comparison purposes, a similar nested case-control analysis for histamine 2 receptor antagonists was performed. MAIN OUTCOME MEASURE: The risk of hip fractures associated with PPI use. RESULTS: There were 13,556 hip fracture cases and 135,386 controls. The adjusted odds ratio (AOR) for hip fracture associated with more than 1 year of PPI therapy was 1.44 (95% confidence interval [CI], 1.30-1.59). The risk of hip fracture was significantly increased among patients prescribed long-term high-dose PPIs (AOR, 2.65; 95% CI, 1.80-3.90; P<.001). The strength of the association increased with increasing duration of PPI therapy (AOR for 1 year, 1.22 [95% CI, 1.15-1.30]; 2 years, 1.41 [95% CI, 1.28-1.56]; 3 years, 1.54 [95% CI, 1.37-1.73]; and 4 years, 1.59 [95% CI, 1.39-1.80]; P<.001 for all comparisons). CONCLUSION: Long-term PPI therapy, particularly at high doses, is associated with an increased risk of hip fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Riggs, B. L., & Melton, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142605 · Cited by 1,915
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Kannus, P., Parkkari, J., Sievänen, H., Heinonen, A., Vuori, I., & Järvinen, M. (1996) · Bone · doi:10.1016/8756-3282(95)00381-9 · Cited by 948
Leibson, C. L., Tosteson, A. N. A., Gabriel, S. E., Ransom, J. E., & Melton, L. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50455.x · Cited by 695
The Read clinical classification.
Chisholm, J. (1990) · BMJ · doi:10.1136/bmj.300.6732.1092 · Cited by 504
Calcium Absorption and Achlorhydria
Recker, R. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130202 · Cited by 502
A Model of Lifetime Osteoporosis Impact
Chrischilles, E. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100100017 · Cited by 467
Biased Selection of Controls for Case-Control Analyses of Cohort Studies
Lubin, J. H., & Gail, M. H. (1984) · Biometrics · doi:10.2307/2530744 · Cited by 414
O’Connell, M. B., Madden, D. M., Murray, A. M., Heaney, R. P., & Kerzner, L. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.007 · Cited by 405
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0021-7 · Cited by 372
Nordin, B. E. C. (1997) · Nutrition · doi:10.1016/s0899-9007(97)83011-0 · Cited by 367
Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Self-citationIncidence of fractures in a geographically defined population.
Donaldson, L. J., Cook, A., & Thomson, R. G. (1990) · Journal of Epidemiology and Community Health · doi:10.1136/jech.44.3.241 · Cited by 297
Cumming, R. G., Nevitt, M. C., & Cummings, S. R. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017956 · Cited by 290
Chemistry of Covalent Inhibition of the Gastric (H+, K+)-ATPase by Proton Pump Inhibitors
Shin, J. M., Cho, Y. M., & Sachs, G. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049607w · Cited by 283
Use of Statins and Risk of Fractures
van Staa, T.-P. (2001) · JAMA · doi:10.1001/jama.285.14.1850 · Cited by 271
Gastrointestinal Absorption of Calcium from Milk and Calcium Salts
Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R., & Fordtran, J. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708273170903 · Cited by 260
Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans
Mizunashi, K., Furukawa, Y., Katano, K., & Abe, K. (1993) · Calcified Tissue International · doi:10.1007/bf01352010 · Cited by 238
The General Practice Research Database: quality of morbidity data.
Hollowell, J. (1997) · PubMed · Cited by 232
Thiazide Diuretics and the Risk for Hip Fracture
Schoofs, M. W. C. J., van der Klift, M., Hofman, A., de Laet, C. E. D. H., Herings, R. M. C., Stijnen, T., Pols, H. A. P., & Stricker, B. H. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00010 · Cited by 221
An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
Bo-Linn, G. W., Davis, G. R., Buddrus, D. J., Morawski, S. G., Santa Ana, C., & Fordtran, J. S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111254 · Cited by 217
Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro
Tuukkanen, J., & Väänänen, H. K. (1986) · Calcified Tissue International · doi:10.1007/bf02556841 · Cited by 164
Van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. M. (2000) · Pharmacoepidemiology and Drug Safety · doi:10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e · Cited by 157
Serfaty-Lacrosnière, C., Wood, R. J., Voytko, D. A., Saltzman, J. R., Pedrosa, M. C., Sepe, T. E., & Russell, R. R. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718522 · Cited by 144
Who is using chronic acid suppression therapy and why?
Jacobson, B. C., Ferris, T. G., Shea, T. L., Mahlis, E. M., Lee, T. H., & Wang, T. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07186.x · Cited by 143
Risk of fractures in patients with pernicious anemia
Goerss, J. B., Kim, C. H., Atkinson, E. J., Eastell, R., O'Fallon, W. M., & Dr. Melton, L. J. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070514 · Cited by 119
Regulation of vitamin D and calcium metabolism after gastrectomy.
Nilas, L., Christiansen, C., & Christiansen, J. (1985) · Gut · doi:10.1136/gut.26.3.252 · Cited by 88
Modularity of osteoclast behaviour and “mode-specific” inhibition of osteoclast function
Zaidi, M. (1990) · Bioscience Reports · doi:10.1007/bf01116615 · Cited by 54
Johansson, S., Wallander, M. ‐., Ruigómez, A., & Rodríguez, L. A. G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01798.x · Cited by 45
Read, J. D. (1990) · BMJ · doi:10.1136/bmj.301.6742.45 · Cited by 39
Pharmacokinetic Study of Omeprazole in Elderly Healthy Volunteers
Landahl, S., Andersson, T., Larsson, M., Lernfeldt, B., Lundborg, P. G., Regårdh, C. G., Sixt, E., & Skånberg, I. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223060-00006 · Cited by 37
Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization
Dawson-Hughes, B. F., Harris, S. S., Dallal, G. E., D. R. Lancaster, & Zhou, Q. (2002) · Osteoporosis International · doi:10.1007/s001980200089 · Cited by 22
Cited by
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001889 · Cited by 1,557
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Self-citationVandenplas, Y., Rudolph, C. D., Committee Members:, Di Lorenzo, C., Hassall, E., Liptak, G., Mazur, L., Sondheimer, J., Staiano, A., Thomson, M., et al. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181b7f563 · Cited by 742
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Metadata
- Authors
- Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-12-27
- Volume
- 296
- Issue
- 24
- Pages
- 2947
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2167359851
- Cited by
- 1,214
- References
- 33
- FWCI
- 67.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.